Surveillance for low-stage testicular cancer

Surveillance of selected patients with clinical stage I germ-cell tumours of the testis is a safe alternative to further immediate treatment. Cure rates appear to be equivalent and are nearly 100%. The morbidity of prophylactic therapy can be avoided in up to 85% of seminoma and 70% of non-seminoma patients who will not progress after orchiectomy alone.